(ALXO) Alx Oncology Holdings - Performance -91.6% in 12m
ALXO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-90.33%
#183 in Peer-Group
Rel. Strength
0.95%
#7602 in Stock-Universe
Total Return 12m
-91.56%
#194 in Peer-Group
Total Return 5y
-98.47%
#174 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 8.13 USD |
| 52 Week Low | 0.41 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 70.69 |
| Buy/Sell Signal +-5 | 1.14 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ALXO (-91.6%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ALXO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALXO
| Total Return (including Dividends) | ALXO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -13.86% | 3.36% | 5.25% |
| 3 Months | -10.82% | 15.73% | 24.13% |
| 12 Months | -91.56% | -7.02% | 14.15% |
| 5 Years | -98.47% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ALXO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -88.4% | 4.4% | 81% |
| 3 Months | -39.7% | 78.8% | 96.9% |
| 12 Months | -94.1% | -85.8% | 44.9% |
| 5 Years | -86.9% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th18.00 | -16.65% | -18.15% |
| 3 Month | %th19.00 | -22.94% | -28.15% |
| 12 Month | %th3.50 | -90.92% | -92.60% |
| 5 Years | %th14.00 | -97.87% | -99.27% |
FAQs
Does Alx Oncology Holdings (ALXO) outperform the market?
No,
over the last 12 months ALXO made -91.56%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months ALXO made -10.82%, while XBI made 15.73%.
Performance Comparison ALXO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ALXO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 11.7% | -19.1% | -80% | -106% |
| US NASDAQ 100 | QQQ | 11.9% | -19.2% | -80.6% | -104% |
| German DAX 40 | DAX | 13.8% | -12.5% | -92.1% | -120% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 11.8% | -17.1% | -83.4% | -111% |
| Hongkong Hang Seng | HSI | 12.1% | -19.9% | -99.4% | -130% |
| India NIFTY 50 | INDA | 13.5% | -17.3% | -80.3% | -91% |
| Brasil Bovespa | EWZ | 9.2% | -22.7% | -105% | -102% |
ALXO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 13.1% | -19.8% | -84.1% | -116% |
| Consumer Discretionary | XLY | 12.2% | -17% | -72.3% | -109% |
| Consumer Staples | XLP | 11.4% | -14.5% | -81.6% | -100% |
| Energy | XLE | 11.4% | -20.9% | -75.9% | -91% |
| Financial | XLF | 11% | -18.9% | -84.9% | -122% |
| Health Care | XLV | 12.2% | -16% | -72.6% | -87% |
| Industrial | XLI | 11.6% | -18.1% | -87.8% | -117% |
| Materials | XLB | 9.4% | -18.1% | -84.5% | -98% |
| Real Estate | XLRE | 11.7% | -14.8% | -79.7% | -104% |
| Technology | XLK | 10.9% | -22.6% | -82.3% | -103% |
| Utilities | XLU | 12.8% | -15.7% | -83.2% | -114% |
| Aerospace & Defense | XAR | 13.8% | -20.9% | -98.5% | -141% |
| Biotech | XBI | 10.7% | -17.2% | -66.8% | -85% |
| Homebuilder | XHB | 9.2% | -20.9% | -72.8% | -97% |
| Retail | XRT | 9.1% | -18.9% | -75.7% | -103% |
ALXO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.8% | -22.3% | -71.6% | -84% |
| Natural Gas | UNG | 21.2% | -4% | -63.2% | -89% |
| Gold | GLD | 11.4% | -12.7% | -100.6% | -131% |
| Silver | SLV | 10.7% | -20.8% | -97.3% | -109% |
| Copper | CPER | 12.6% | -18.5% | -97% | -102% |
ALXO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 13.5% | -14.9% | -76.5% | -90% |
| iShares High Yield Corp. Bond | HYG | 12.9% | -15.5% | -78.9% | -102% |